Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|
| LiabilitiesEquity Capital | 18 | 18 | 19 | 19 |
| Reserves | 61 | 72 | 86 | 85 |
| Borrowings | 35 | 60 | 58 | 68 |
| Other Liabilities | 22 | 40 | 47 | 41 |
| Total Liabilities | 135 | 190 | 210 | 213 |
| AssetsFixed Assets | 24 | 53 | 55 | 57 |
| CWIP | 2 | 3 | 0 | 0 |
| Investments | 2 | 3 | 1 | 5 |
| Other Assets | 108 | 131 | 154 | 150 |
| Total Assets | 135 | 190 | 210 | 213 |
| Line item | FY24 | FY25 | FY26 |
|---|---|---|---|
| ActivitiesCash from Operating | 1 | 20 | 19 |
| Cash from Investing | -3 | -45 | -20 |
| Cash from Financing | 0 | 26 | 1 |
| SummaryCapital Expenditure | — | — | — |
| Free Cash Flow | 1 | 20 | 19 |
| FCF Margin | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (14.8×) and current (20.9×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 10% growth and a 15× exit, ₹110 only delivers your return if you pay ₹55. The price is currently baking in 25% growth.
EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 15×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 10.0% | 5.79 |
| FY28 | 10.0% | 6.36 |
| FY29 | 10.0% | 7.00 |
| FY30 | 10.0% | 7.70 |
| FY31 | 10.0% | 8.47 |
| FY32 | 8.0% ·fade | 9.15 |
| FY33 | 6.0% ·fade | 9.70 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.